How often is Semaglutide GLP-1 administered for weight loss
By November 30, 2024, the FDA received more than 392 reports of adverse events in patients using compounded semaglutide
Table of Contents Why Ozempic Can Cause Nausea and Vomiting Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus
Stimulant laxatives should only be used short-term and after medical advice, per NHS guidance
While tirzepatide had a high number of reported adverse events overall, serious safety signals were not disproportionately higher than those of other GLP-1 RAs
European Union Recommended NAION Warnings In June 2025, the European Medicines Agency (EMA) recommended updating the labeling for semaglutide to list NAION as a very rare side effect, affecting up to 1 in 10,000 users